CLINICAL SUPPLY MANAGEMENT ARTICLES
More Than Half The Drug We Make Never Reaches A Patient
More than half the drug made for clinical trials may never reach a patient. Here’s where supply planning goes wrong, and where AI can actually help.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
To better understand sponsors’ perspectives on DTP distribution of clinical supplies, 234 individuals involved in clinical supply and operations were recently surveyed. Click to get the results!
-
Shipping and storing advanced therapeutics are complex processes, but advancements in accountability, wearables, and technology capture real-time factors critical to safety and protocol.
-
Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
-
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
Shipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them.
-
Clinical trials can be very complex. Discover the need to connect planning and oversight from sourcing to shipping, along with mastering requirements such as cold chain, border slowdowns, and data privacy.
-
Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.